Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
0.1169
Dollar change
-0.0002
Percentage change
-0.17
%
Index- P/E- EPS (ttm)-0.48 Insider Own16.66% Shs Outstand65.56M Perf Week-2.26%
Market Cap7.66M Forward P/E- EPS next Y-0.10 Insider Trans0.00% Shs Float54.64M Perf Month0.43%
Income-6.39M PEG- EPS next Q-0.04 Inst Own1.84% Short Float0.93% Perf Quarter-29.15%
Sales0.02M P/S383.20 EPS this Y75.00% Inst Trans4.59% Short Ratio0.18 Perf Half Y-72.23%
Book/sh0.14 P/B0.86 EPS next Y47.50% ROA-89.51% Short Interest0.51M Perf Year-88.65%
Cash/sh0.11 P/C1.08 EPS next 5Y- ROE-152.61% 52W Range0.11 - 1.49 Perf YTD-31.64%
Dividend Est.- P/FCF- EPS past 5Y- ROI-70.28% 52W High-92.15% Beta3.46
Dividend TTM- Quick Ratio4.32 Sales past 5Y-56.05% Gross Margin-69.88% 52W Low5.70% ATR (14)0.01
Dividend Ex-Date- Current Ratio4.71 EPS Y/Y TTM16.67% Oper. Margin-32390.53% RSI (14)44.36 Volatility4.19% 9.21%
Employees12 Debt/Eq0.12 Sales Y/Y TTM100.02% Profit Margin-34362.39% Recom1.00 Target Price0.68
Option/ShortNo / Yes LT Debt/Eq0.05 EPS Q/Q80.96% Payout- Rel Volume0.51 Prev Close0.12
Sales Surprise- EPS Surprise50.00% Sales Q/Q653.85% EarningsMar 14 AMC Avg Volume2.85M Price0.12
SMA20-6.71% SMA50-7.21% SMA200-72.75% Trades Volume1,461,350 Change-0.17%
Mar-26-24 09:00AM
Mar-14-24 09:54PM
04:15PM
Mar-12-24 09:00AM
Mar-06-24 09:20AM
09:00AM Loading…
09:00AM
Feb-26-24 09:00AM
Feb-12-24 09:00AM
Feb-01-24 09:00AM
Jan-18-24 08:00AM
Jan-03-24 04:15PM
Dec-18-23 11:52AM
Dec-14-23 04:15PM
Dec-05-23 08:00AM
Nov-20-23 08:00AM
08:07AM Loading…
Nov-15-23 08:07AM
Nov-13-23 08:45AM
Nov-08-23 07:54AM
Oct-19-23 09:00AM
Sep-26-23 08:00AM
Sep-25-23 08:00AM
Sep-21-23 08:00AM
Sep-14-23 04:15PM
Sep-12-23 04:15PM
Sep-11-23 04:15PM
Sep-07-23 09:00AM
Aug-31-23 09:00AM
Aug-24-23 09:00AM
Aug-17-23 10:36AM
09:00AM
09:00AM Loading…
Jul-27-23 09:00AM
Jul-19-23 09:00AM
May-17-23 08:00AM
May-09-23 08:15AM
May-08-23 08:15AM
May-02-23 08:15AM
Apr-24-23 09:00AM
Apr-17-23 08:15AM
Mar-18-23 08:39AM
Mar-16-23 04:15PM
Feb-07-23 11:04AM
Feb-06-23 07:30AM
Feb-03-23 09:00AM
Jan-24-23 11:00AM
Jan-23-23 09:00AM
Jan-20-23 09:00AM
Jan-04-23 09:00AM
Dec-16-22 08:30AM
Dec-01-22 09:00AM
Nov-28-22 09:00AM
Nov-21-22 09:00AM
Nov-10-22 09:00AM
Oct-25-22 09:00AM
Oct-20-22 09:00AM
Oct-19-22 09:15AM
08:45AM
Oct-18-22 09:00AM
Oct-06-22 09:00AM
Sep-20-22 08:30AM
Sep-13-22 08:00AM
Sep-12-22 08:30AM
Sep-08-22 08:30AM
Aug-01-22 08:30AM
Jul-13-22 02:03PM
Jun-15-22 09:50AM
Heart Test Laboratories, Inc. is a medical technology company, which focuses on applying innovative AI-based technology to an electrocardiogram (ECG) to expand and improve an ECG's clinical usefulness. Its objective is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It offers MyoVista, a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction. The company was founded in 2008 and is headquartered in Southlake, TX.